GE provides gas engines to African anti-malaria equipment manufacturer
IMIL is undergoing a project to meet the needs for syringes and IV products in Nigeria that help protect citizens from malaria. The project is projected to cost $275 million for the creation of one billion syringes, one billion hypodermic needles, 105 million sets of IV bags and 90 million liters of IV solutions, medications and injections annually.
The World Health Organization said that half of the world's population is at risk of contracting malaria, especially in poorer regions. In 2010, the WHO reported 90 percent of all malaria deaths occurred in the Western regions of Africa, predominantly taking the lives of children five years old and under.
There is a high demand for these anti-malaria medical supplies, and this initiative is an important part of fighting the battle. The facility the IMIL will be using needs a power supply that is reliable, the organization said, to ensure the syringes are not damaged and is capable produce the billions of supplies it's expected to.
The new installations will use gas instead of diesel fuel, saving the company resources because gas is more cost-effective. The plant will be using these units in conjunction with the existing gas network in Nigeria.
The IMIL is the first organization to gain pre-qualification for auto-disable syringes from the WHO in Western African sub-regions. It was established by the Pan African Health Foundation and the Rivers State Government; it is currently owned by the Rivers State Government.
GE will deliver the equipment in the third quarter of 2013. The initiative is planned to begin in 2014.